Aberrant Phenotypes in Peripheral T Cell Lymphomas
Overview
Authors
Affiliations
Seventy six peripheral T cell lymphomas were examined immunohistologically to test their reactivity with a panel of monoclonal antibodies against 11 T cell associated antigens (CD1-8, CD27, UCHL1, and the T cell antigen receptor). Sixty two (82%) lymphomas showed aberrant phenotypes, and four main categories were distinguished as follows: (i) lack of one or several pan-T cell antigens (49, 64% of the cases); (ii) loss of both the CD4 and CD8 antigens (11, 15% of the cases); (iii) coexpression of the CD4 and CD8 antigens (13, 17% of the cases); and (iv) expression of the CD1 antigen (eight, 11% of the cases). No correlation was seen between the occurrence of aberrant phenotypes and the histological subtype. It is concluded that the demonstration of an aberrant phenotype is a valuable supplement to histological assessment in the diagnosis of peripheral T cell lymphomas. It is recommended that the panel of monoclonal antibodies against T cell differentiation antigens should be fairly large, as apparently any antigen may be lost in the process of malignant transformation.
Insights Into the Molecular and Cellular Underpinnings of Cutaneous T Cell Lymphoma.
Yumeen S, Girardi M Yale J Biol Med. 2020; 93(1):111-121.
PMID: 32226341 PMC: 7087059.
Aberrant phenotypes in Kikuchi's disease.
Wei X, Zhou X, Xie J, Zheng X, Zheng Y Int J Clin Exp Pathol. 2014; 7(9):5557-63.
PMID: 25337197 PMC: 4203168.
Piccaluga P, Agostinelli C, Califano A, Rossi M, Basso K, Zupo S J Clin Invest. 2007; 117(3):823-34.
PMID: 17304354 PMC: 1794115. DOI: 10.1172/JCI26833.
Washington L, Huh Y, Powers L, Duvic M, Jones D BMC Clin Pathol. 2002; 2(1):5.
PMID: 12475398 PMC: 140025. DOI: 10.1186/1472-6890-2-5.
Hodgkin's lymphoma: the pathologist's viewpoint.
Pileri S, Ascani S, Leoncini L, Sabattini E, Zinzani P, Piccaluga P J Clin Pathol. 2002; 55(3):162-76.
PMID: 11896065 PMC: 1769601. DOI: 10.1136/jcp.55.3.162.